Leicester Cancer Research Centre
People
Directors
Professor Don Jones
- Professor in Translational Biomarkers
- Head of Division of Cancer Sciences
- Research in application of Mass Spectrometry in Biomarker discovery through to clinical implementation
Professor Leong L Ng
- Professor of Medicine and Therapeutics
- Consultant Physician
- Research in Biomarkers of Heart Failure including NT-ProBNP, PENK and second generation risk markers
Dr Pankaj Gupta
- Consultant Chemical Pathologist and Metabolic Physician
- Co-Director National Centre for Adherence Testing (NCAT)
- Vice-Chair, Working Group on Cardiovascular Pharmacotherapy and Adherence. European Society of Hypertension
- Translational Research in drug adherence particularly around hypertension drugs
Professor Toru Suzuki
- Professor of Cardiovascular Medicine
- Leicester PI for the UK Consortium on MetAbolic Phenotyping (MAPUK)
- Research in Aortic Disease and novel CVD markers from the Gut/Heart axis including TMAO
- Co-lead of LeDucq Network of Excellence
Post-Doctoral Staff
Dr Dennis Bernieh
- Research Fellow
- Proteomics, Metabolomics, Microsampling, Biomarker discovery/validation
- Involves the application of mass spectrometry-based omics approaches to understand how fundamental metabolic processes are altered in multimorbid cardiovascular disease
Dr Thong Huy Cao (MD, MSc Med, PhD)
- Research Associate (funded by the NIHR Leicester Biomedical Research Centre)
- Clinician–scientist with experience in cardiology, cardiovascular research, and student supervision in clinical and translational science, as well as experience in teaching and clinical instruction for medical students
- Heart failure (HFrEF, HFpEF, HFimpEF), mass spectrometry-based multi-omics (proteomics, metabolomics, lipidomics), biomarker discovery for risk stratification, prognosis, and precision medicine and identification of novel therapeutic targets
Dr Cao's ORCID profile Dr Cao's Profile
Dr Dan Lane
- Post-Doctoral Research Associate (funded by the NIHR Leicester Biomedical Research Centre)
- Method development, validation, and clinical translation for mass spectrometry tests for both small molecule (adherence testing/therapeutic drug monitoring) and bottom-up proteomics (hypertension). Biomarker discovery for cardiometabolic diseases. Development of software (ValidateLabs™) for validation data processing
- Automation and development of rapid multiplexed assays for clinical use and commercialisation
Dr Ellen Liggett
- Post-Doctoral Research Associate (Funded by the BHF Leicester Centre of Research Excellence)
- Structural Mass Spectrometry and Proteomics
- Cardiovascular Interventions
Dr Colleen Maxwell
- Post-Doctoral Research Associate (funded by the British Heart Foundation)
- BHF project grant investigating a novel proteomic panel for the exclusion of coronary artery disease in low-risk individuals
- Particularly interested in developing high throughput, scalable bottom-up proteomics protocols and LC-MS methods that can be applied to large clinical cohorts
Dr Farah Salim
- Post-Doctoral Research Associate (funded by the NIHR Leicester Biomedical Research Centre)
- Mass spectrometry based proteomic and metabolomic research to identify and validate biomarkers of early heart failure in people with type 2 diabetes
- High-throughput proteomic and small-molecule LC-MS assay development, optimisation, and validation for application in large clinical cohorts
Dr Jodie Sandhu
- Post-Doctoral Research Associate (Funded by the British Heart Foundation)
- Metabolomic and Lipidomic profiling in T2D patients with asymptomatic Heart Failure
- Metabolomics, Lipidomics and targeted MS Assays in Cardiovascular Research
Dr Gez Williams
- Post-Doctoral Research Associate (Funded by the British Heart Foundation)
- BHF funded Research in asymptomatic aortic stenosis and sudden cardiac death experience in proteomics discovery and targeted as well as discovery metabolomics
- IAA-MRC funded woman’s health research project: Sex-Based Differences in Guideline-Directed Medical Therapy (GDMT) Plasma Levels
Technical staff
Dr Raj Singh
- Mass Spectrometry Manager
- Research interests in Biomarkers, Biomonitoring and molecular elucidation
- Experience in DNA adduct method development, drug metabolite ID and all aspects of LC-MS